RxSight's Earnings Outlook
Portfolio Pulse from Benzinga Insights
RxSight (NASDAQ:RXST) is anticipated to report a Q4 earnings per share (EPS) of $-0.36 on February 28, 2024. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, RxSight has exceeded EPS estimates, leading to significant stock price movements. The company's shares have seen a 334.12% increase over the last 52 weeks, trading at $56.41 as of February 26.
February 27, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RxSight is expected to report a Q4 EPS of -$0.36 on February 28, 2024. The company's historical performance of beating EPS estimates has positively impacted its stock price, with a 334.12% increase over the last 52 weeks.
RxSight's history of surpassing EPS estimates has previously led to positive stock price movements. Given the company's past performance and the significant year-to-date increase in share price, a positive earnings report and guidance could likely lead to further stock appreciation in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100